Barclays PLC Cara Therapeutics, Inc. Transaction History

Barclays PLC

$288 Billion
Q1 2024

A detailed history of Barclays PLC transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Barclays PLC holds 32,422 shares of CARA stock, worth $10,699. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,422

Previous 64,012 49.35%

Holding current value

$10,699

Previous $47,000 38.3%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.52 - $1.05 $16,426 - $33,169	-31,590 Reduced 49.35%	32,422 $29,000
Q4 2023 Feb 15, 2024	BUY	$0.6 - $1.65 $33,710 - $92,703	56,184 Added 717.73%	64,012 $47,000
Q3 2023 Nov 07, 2023	SELL	$1.67 - $3.33 $2,535 - $5,054	-1,518 Reduced 16.24%	7,828 $13,000
Q2 2023 Aug 03, 2023	SELL	$2.83 - $4.94 $54,019 - $94,294	-19,088 Reduced 67.13%	9,346 $26,000
Q1 2023 May 04, 2023	SELL	$4.89 - $12.27 $4,890 - $12,270	-1,000 Reduced 3.4%	28,434 $141,000

Q4 2022 Feb 13, 2023	BUY	$8.88 - $12.77 $104,233 - $149,894	11,738 Added 66.33%	29,434 $316,000
Q3 2022 Nov 03, 2022	SELL	$8.24 - $12.56 $144,488 - $220,239	-17,535 Reduced 49.77%	17,696 $166,000
Q2 2022 Aug 12, 2022	SELL	$7.45 - $13.84 $41,556 - $77,199	-5,578 Reduced 13.67%	35,231 $322,000
Q1 2022 May 16, 2022	SELL	$9.94 - $12.65 $396,248 - $504,279	-39,864 Reduced 49.41%	40,809 $496,000
Q4 2021 Feb 14, 2022	BUY	$11.99 - $18.14 $359,364 - $543,692	29,972 Added 59.12%	80,673 $983,000
Q3 2021 Nov 09, 2021	BUY	$11.55 - $16.06 $267,740 - $372,286	23,181 Added 84.23%	50,701 $782,000
Q2 2021 Aug 13, 2021	SELL	$12.38 - $29.19 $153,437 - $361,780	-12,394 Reduced 31.05%	27,520 $393,000
Q1 2021 May 13, 2021	BUY	$15.07 - $21.71 $351,507 - $506,385	23,325 Added 140.61%	39,914 $867,000
Q4 2020 Feb 11, 2021	SELL	$12.72 - $16.16 $70,163 - $89,138	-5,516 Reduced 24.95%	16,589 $251,000
Q3 2020 Nov 12, 2020	SELL	$12.34 - $17.92 $113,959 - $165,491	-9,235 Reduced 29.47%	22,105 $282,000
Q2 2020 Aug 12, 2020	BUY	$12.39 - $17.33 $186,097 - $260,296	15,020 Added 92.03%	31,340 $536,000
Q1 2020 May 13, 2020	SELL	$9.12 - $17.78 $482,347 - $940,366	-52,889 Reduced 76.42%	16,320 $216,000
Q4 2019 Feb 10, 2020	BUY	$16.11 - $25.98 $172,087 - $277,518	10,682 Added 18.25%	69,209 $1.11 Million
Q3 2019 Nov 14, 2019	BUY	$18.28 - $26.91 $511,419 - $752,861	27,977 Added 91.58%	58,527 $1.07 Million
Q2 2019 Aug 14, 2019	SELL	$17.68 - $21.57 $592,580 - $722,961	-33,517 Reduced 52.32%	30,550 $657,000
Q1 2019 May 15, 2019	SELL	$14.41 - $19.64 $141,664 - $193,080	-9,831 Reduced 13.3%	64,067 $1.26 Million
Q4 2018 Feb 14, 2019	BUY	$12.45 - $23.47 $555,157 - $1.05 Million	44,591 Added 152.15%	73,898 $961,000
Q3 2018 Nov 14, 2018	SELL	$17.57 - $23.95 $1.05 Million - $1.43 Million	-59,625 Reduced 67.05%	29,307 $701,000
Q2 2018 Aug 14, 2018	BUY	$11.6 - $19.27 $937,628 - $1.56 Million	80,830 Added 997.65%	88,932 $1.7 Million
Q1 2018 May 15, 2018	SELL	$11.77 - $16.08 $139,309 - $190,322	-11,836 Reduced 59.36%	8,102 $99,000
Q4 2017 Feb 14, 2018	SELL	$11.86 - $14.08 $780,115 - $926,140	-65,777 Reduced 76.74%	19,938 $244,000
Q3 2017 Nov 14, 2017	BUY	$12.6 - $16.34 $1.08 Million - $1.4 Million	85,715	85,715 $1.17 Million

Others Institutions Holding CARA

# of Institutions

102

Shares Held

21.5M

Call Options Held

50K

Put Options Held

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $17.7M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account